Form 4: MDWerks Director Acquires 44,874 Shares in Planned Grant

MDWerks Director Timothy Brocopp acquired 44,874 shares of common stock at $0.22 per share as part of a pre-planned compensation agreement.

Summary

• Director Timothy Brocopp acquired 44,874 shares of MDWerks, Inc. common stock.
• The transaction occurred on June 2, 2025, at a price of $0.22 per share.
• This acquisition was a grant of shares issued on a quarterly basis, pursuant to an Employment Agreement entered into on November 18, 2024.
• The grant was approved by the Issuer's board of directors and complied with Rule 16b-3 promulgated under the Securities Exchange Act of 1934.
• Following this transaction, Mr. Brocopp beneficially owns 2,925,352 shares of MDWerks common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially as part of a pre-planned compensation agreement, generally signals confidence in the company's future and aligns management's interests with shareholders. It's a routine, positive governance event.

Positives

• Director Timothy Brocopp increased his direct ownership in MDWerks, Inc. by 44,874 shares, demonstrating continued alignment with shareholder interests.
• The acquisition was part of a pre-planned compensation agreement (Rule 10b5-1(c) plan), indicating a structured approach to executive compensation and long-term commitment.
• The grant was approved by the board of directors and complied with SEC Rule 16b-3, ensuring proper corporate governance and regulatory adherence.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the execution of a pre-planned compensation agreement.

Industry Context

This Form 4 filing details an insider stock acquisition, a routine event in corporate governance. Such transactions are generally viewed as a positive signal of management's confidence in the company's future, especially when part of a pre-planned compensation structure. The specific industry context of MDWerks, Inc. is not detailed in this filing, but insider buying can be a general indicator of internal sentiment.

Comparison to Industry Standards

• Insider acquisitions, particularly those under Rule 10b5-1 plans, are a common form of executive compensation and alignment strategy across various industries. For example, similar grants are observed in technology companies like Microsoft (MSFT) or healthcare firms like Johnson & Johnson (JNJ) where executives receive equity as part of their remuneration packages to align their interests with long-term shareholder value.
• The price of $0.22 per share is specific to MDWerks and cannot be directly compared to industry giants without knowing the company's market capitalization, sector, and stage of development. However, the mechanism of equity compensation is standard.

Corporate Governance

Related Party Transactions

• The grant of shares to Director Timothy Brocopp is a related party transaction, as it involves compensation to a director of the company.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholder value through increased equity ownership.
• Employees: Demonstrates a structured approach to executive compensation, potentially setting a precedent for other key personnel.

Next Steps

• Future quarterly grants of common stock to Timothy Brocopp are expected to occur as per the Employment Agreement dated November 18, 2024.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider acquisition of shares as part of executive compensation. While it signals director confidence and aligns interests, it does not present new fundamental information or a significant change in the company's outlook that would warrant a 'buy' or 'sell' recommendation. It's an expected event, thus maintaining a 'hold' position is appropriate based solely on this filing.

Keywords

MDWerks, MDWK, Timothy Brocopp, Director, Insider Trading, Share Acquisition, Common Stock, Form 4, SEC Filing, Beneficial Ownership, Executive Compensation, Rule 10b5-1